Addmedica Revenue and Competitors
Estimated Revenue & Valuation
- Addmedica's estimated annual revenue is currently $5.4M per year.
- Addmedica's estimated revenue per employee is $201,000
Employee Data
- Addmedica has 27 Employees.
- Addmedica grew their employee count by -44% last year.
Addmedica's People
Name | Title | Email/Phone |
---|
Addmedica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $50.7M | 252 | 11% | N/A | N/A |
#2 | $18.3M | 91 | -5% | N/A | N/A |
#3 | $33.4M | 166 | -8% | N/A | N/A |
#4 | $41M | 204 | 32% | N/A | N/A |
#5 | $220.1M | 1095 | 27% | N/A | N/A |
#6 | $54.5M | 271 | 2% | N/A | N/A |
#7 | $58.1M | 289 | 20% | N/A | N/A |
#8 | $19.7M | 98 | -11% | N/A | N/A |
#9 | $18.5M | 92 | -16% | N/A | N/A |
#10 | $31.6M | 157 | 15% | N/A | N/A |
What Is Addmedica?
addmedica is a fast growing company focused on developing and marketing medical products for: • rare diseases • unmet medical needs in developed and emerging countries • serious conditions addmedica is dedicated to providing high medical value to physicians, patients, and managed care organizations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases. addmedica's strategic areas of interest comprise: • wound healing, tissue growth and cell regeneration • organ transplant, tissue replacement • genetic diseases, drug or substitute therapy, cell or gene therapy addmedica, complying with its pharmaceutical status, is proud to offer a range of products in the fields of • lung transplantation, • wound healing and deep burn care. • sickle cell disease (European Orphan Medicinal Product) addmedica is constantly looking for new opportunities and partnerships, to develop and commercialize products with high medical demand. As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading firm for the provision of medical products and innovative techniques for rare diseases with the best quality of services.
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.4M
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Addmedica News
Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc; Bristol-Myers...
Addmedica; Gamida Cell; Glycomimetics; Pfizer; Novartis; Global Blood Therapeutics; Micelle Biopharma; Bluebird Bio; Prolong Pharmaceuticals...
Addmedica SAS; Angiocrine Bioscience Inc; Annexin Pharmaceuticals AB; ArQule Inc; Bio Products Laboratory Ltd; Bioverativ Inc; bluebird bio Inc...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 27 | N/A | N/A |
#2 | $2.7M | 27 | N/A | N/A |
#3 | $2.7M | 27 | -23% | N/A |
#4 | $2.7M | 27 | -45% | N/A |
#5 | $2.7M | 27 | 35% | N/A |